The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether intermittent real-time continuous glucose monitoring (CGM) improves glycemic control and pregnancy outcome in unselected women with pregestational diabetes. RESEARCH DESIGN AND METHODS: A total of 123 women with type 1 diabetes and 31 women with type 2 diabetes were randomized to use real-time CGM for 6 days at 8, 12, 21, 27, and 33 weeks in addition to routine care, including self-monitored plasma glucose seven times daily, or routine care only. To optimize glycemic control, real-time CGM readings were evaluated by a diabetes caregiver. HbA1c, self-monitored plasma glucose, severe hypoglycemia, and pregnancy outcomes were recorded, with large-for-gestational-age infants as the primary outcome. RESULTS: Women assigned to real-time CGM (n = 79) had baseline HbA1c similar to that of women in the control arm (n = 75) (median 6.6 [range 5.3–10.0] vs. 6.8% [5.3–10.7]; P = 0.67) (49 [34–86] vs. 51 mmol/mol [34–93]). Forty-nine (64%) women used real-time CGM per protocol. At 33 weeks, HbA1c (6.1 [5.1–7.8] vs. 6.1% [4.8–8.2]; P = 0.39) (43 [32–62] vs. 43 mmol/mol [29–66]) and self-monitored plasma glucose (6.2 [4.7–7.9] vs. 6.2 mmol/L [4.9–7.9]; P = 0.64) were comparable regardless of real-time CGM use, and a similar fraction of women had experienced severe hypoglycemia (16 vs. 16%; P = 0.91). The prevalence of large-for-gestational-age infants (45 vs. 34%; P = 0.19) and other perinatal outcomes were comparable between the arms. CONCLUSIONS: In this randomized trial, intermittent use of real-time CGM in pregnancy, in addition to self-monitored plasma glucose seven times daily, did not improve glycemic control or pregnancy outcome in women with pregestational diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There was also lower incidence of large for gestational age (odds ratio [OR], 0.51; 95% CI, 0$28–0.90; P = .0210)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“The CONCEPTT study’s participants were randomly assigned to either CGM in addition to capillary glucose monitoring or capillary glucose monitoring alone and showed a modest reduction in A1C levels, increased time in target, reduced hyperglycemia, and less glycemic variability.123”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and 1-day shorter length of hospital stay (P = .0091) in women with T1D on multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer incidences of neonatal hypoglycemia (0.45; 95% CI, 0.22–0.89; P = .0250)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer neonatal intensive care admissions lasting more than 24 hours (0.48; 95% CI, 0.26–0.86; P = .0157)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrauterine growth curves based on ultrasonically estimated foetal weights
Maršál, K., Persson, P., Larsen, T., Lilja, H., Selbing, A., & Sultan, B. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14164.x · Cited by 1,865 · cited 1×
“, infant birth weight $90th centile adjusted for sex and gestational age (31)] was predefined as the primary outcome of this study.”
MethodContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Clausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., & Damm, P. (2008) · Diabetes Care · doi:10.2337/dc07-1596 · Cited by 724
Self-citationPickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 2×
“Recent data indicate the importance of frequent real-time CGM use (16).”
BackgroundDeiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Murphy, H. R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J., & Temple, R. C. (2008) · BMJ · doi:10.1136/bmj.a1680 · Cited by 358 · cited 6×
“However, the relatively low number of per-protocol users has also been observed in the nonpregnant population (17,18), and the average use of CGM was comparable to the former study on pregnant women (27).”
BackgroundResultInfluentialHbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Self-citationEffectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Items 101–200 of 243
Ásbjörnsdóttir, B., Ronneby, H., Vestgaard, M. J., Ringholm, L., Nichum, V. L., Jensen, D. M., Raben, A., Damm, P., & Mathiesen, E. R. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.012 · Cited by 19
Self-citationA Perspective on the Accuracy of Blood Glucose Meters During Pregnancy
Immanuel, J., & Simmons, D. S. (2018) · Diabetes Care · doi:10.2337/dc18-0833 · Cited by 18
“pliance was 64% (31) and 80% (32); thus, such devices are not suitable for all women.”
BackgroundResultPathologies maternelles chroniques et pertes de grossesse. Recommandations françaises
Nizard, J., Guettrot-Imbert, G., Plu‐Bureau, G., Ciangura, C., Jacqueminet, S., Leenhardt, L., Nedellec, S., Gallot, V., Vialard, F., Quibel, T., et al. (2014) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2014.09.017 · Cited by 18
Song, Y., Zhai, X., Bai, Y., Liu, C., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1218602 · Cited by 17
Wang, Z., James-Todd, T. M., ISGANAITIS, E. M., O'CONNELL, J. C., Helman, S., Wyckoff, J., Serdy, S., Halprin, E., O’Brien, K., Gupta, M., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109854 · Cited by 17
Knorr, S., Juul, S., Bytoft, B., Lohse, Z., Clausen, T. D., Jensen, R. B., Damm, P., Beck‐Nielsen, H., Mathiesen, E. R., Jensen, D. M., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4575-5 · Cited by 17
“In a Danish study, Secher et al [31] described tighter glycaemic control among pregnant women with type 1 diabetes between 2009 and 2011 than among the women included in our study.”
BackgroundSelf-citationGlycemic Status Assessment by the Latest Glucose Monitoring Technologies
Malandrucco, I., Russo, B., Picconi, F., Menduni, M., & Frontoni, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218243 · Cited by 17
“, did not find evidence of an improvement in glycemic control or pregnancy outcomes in their study of 123 women with T1D in MDI or insulin pump that used intermittent CGM [88].”
BackgroundPolsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16
Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0973-9 · Cited by 16
Pamidi, S., Meltzer, S. J., Garfield, N., Lavigne, L., Olha, A., Khalyfa, A. A., Benedetti, A., Tremblay, G., Gagnon, R. J., Rey, É., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00659 · Cited by 16
Vestgaard, M. J., Secher, A. L., Ringholm, L., Jensen, J. B., Damm, P., & Mathiesen, E. R. (2017) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13180 · Cited by 16
Self-citationContinuous Glucose Monitoring in Pregnancy
Horgan, R., Diab, Y. H., Bartal, M. F., Sibai, B. M., & Saade, G. R. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005374 · Cited by 15
Use of continuous glucose monitoring and hybrid closed‐loop therapy in pregnancy
Benhalima, K., & Yamamoto, J. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15999 · Cited by 15
“25 This study showed no improvement in HbA1c levels nor improvement in pregnancy outcomes.”
Continuous glucose monitoring system in diabetes in pregnancy: a narrative review
Rodacki, M., Krakauer, M., Franco, D. R., Dualib, P. M., Sancovski, M., & Zajdenverg, L. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01854-x · Cited by 15
The use of insulin detemir during pregnancy: a safety evaluation
Koren, R., Toledano, Y., & Hod, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1013533 · Cited by 14
Eberle, C., Löhnert, M., & Stichling, S. (2021) · Journal of Medical Internet Research · doi:10.2196/24982 · Cited by 15
Levy, C. J., Foster, N. C., DuBose, S. N., Agarwal, S., Lyons, S. K., Peters, A. L., Uwaifo, G. I., DiMeglio, L. A., Sherr, J. L., & Polsky, S. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820972123 · Cited by 14
Carreiro, M. P., Lauria, M. W., Naves, G. N. T., Miranda, P. A. C., Leite, R. B., Rajão, K. M. A. B., de Aguiar, R. A. L. P., Nogueira, A. I., & Ribeiro‐Oliveira, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0015 · Cited by 14
The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges
Werzowa, J. M., Hecking, M., Haidinger, M., Döller, D., Sharif, A., Tura, A., & Säemann, M. D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0601-x · Cited by 14
Gunabalasingam, S., Kyrka, A., Hopkins, L., Lebrett, R., Dyer, E., Forde, R., Heslehurst, N., Meek, C. L., Schoenaker, D. A. J. M., Flynn, A. C., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15474 · Cited by 13
“17,20,24 In the coming years, this area will be addressed by studies such as the PROTECT trial (https:// www. isrctn. com/ ISRCT N1280 4317) and the CGM2 trial (https:// repor ter. nih. gov/ search/ 7AGH8 2-JnE2R TnZ4cj_ sJQ/ proje ct-detai ls/ 10776545).”
Li, S., Guo, H., Zhang, Y., Li, P., Zhou, P., Li-rong, S., Li, J., & Chen, L. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00657-0 · Cited by 13
Glucose Treatment Targets in Pregnancy - A Review of Evidence and Guidelines
Byford, A. R., Forbes, K. A., & SCOTT, E. M. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220422083935 · Cited by 13
Bongiovanni, M., Fresa, R., Visalli, N., Bitterman, O., SURACI, C., & Napoli, A. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0246 · Cited by 13
A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture
Murphy, H. R. (2024) · Diabetes Care · doi:10.2337/dci23-0067 · Cited by 12
Treating to Target Glycaemia in Type 2 Diabetes Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220201111200 · Cited by 12
Sibiak, R., Mantaj, U., Gutaj, P., Zozulińska‐Ziółkiewicz, D., & Wender-Ożegowska, E. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16501 · Cited by 12
Zhen, X. M., Li, X., & Chen, C. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.08.001 · Cited by 12
Maiorino, M. I., Petrizzo, M., Bellastella, G., & Esposito, K. (2017) · Endocrine · doi:10.1007/s12020-017-1328-z · Cited by 11
The role of continuous glucose monitoring in pregnancy
Li, A., & Brackenridge, A. (2021) · Obstetric Medicine · doi:10.1177/1753495x211014716 · Cited by 11
Assessing Glycemic Control Using CGM for Women with Diabetes in Pregnancy
O’Malley, G., Wang, A., OGYAADU, S. J., & Levy, C. J. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01415-2 · Cited by 12
Diabetes Mellitus in Pregnancy
Goodman, J. R. (2023) · NeoReviews · doi:10.1542/neo.24-3-e144 · Cited by 11
Continuous Glucose Monitoring in Pregnancy: New Frontiers in Clinical Applications and Research
Sung, J. F., Taslimi, M. M., & Faig, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600629 · Cited by 11
Severe hypoglycemia in pregnant women with type 2 diabetes—A relevant clinical problem
Secher, A. L., Mathiesen, E. R., Andersen, H. U., Damm, P., & Ringholm, L. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.011 · Cited by 11
Self-citationUtilization of wearable technology data in chronic disease management
Oni, O., & Awofala, T. B. (2022) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2022.16.3.1208 · Cited by 10
Roadmap to the Effective Use of Continuous Glucose Monitoring in Pregnancy
Murphy, H. R. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0004 · Cited by 10
Continuous Glucose Monitoring in Pregnancy: We Have the Technology but Not All the Answers
Murphy, H. R. (2013) · Diabetes Care · doi:10.2337/dc13-0273 · Cited by 10
“(6) report on their results from a randomized controlled trial of intermittent real-time continuous glucose monitoring (CGM) in pregnant women with diabetes.”
BackgroundMcCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Ye, S., Shahid, I., Yates, C. J., Kevat, D., & Lee, I. (2024) · Obstetric Medicine · doi:10.1177/1753495x241258668 · Cited by 8
Glucose Control During Labour and Delivery in Type 1 Diabetes – An Update on Current Evidence
Ringholm, L., Søholm, J. C., Pedersen, B. W., Clausen, T. D., Damm, P., & Mathiesen, E. R. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01563-1 · Cited by 8
Self-citationTonoike, M., Kishimoto, M., Yamamoto, M., Yano, T., & Noda, M. (2016) · Japanese Clinical Medicine · doi:10.4137/jcm.s34825 · Cited by 8
Restrepo-Moreno, M., Rincón, A. R., Hincapié-García, J. A., Palacio, A., Monsalve, C., Aristizabal-Henao, N., Restrepo-Zapata, C., & Botero, J. F. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1295952 · Cited by 8
Farrar, D., & Campbell, M. D. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.03.08 · Cited by 8
Resi, V., Bianchi, C., Burlina, S., Grancini, V., Manicardi, E., Masulli, M., Scarpitta, A. M., Sorice, G. P., & Fresa, R. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02592-2 · Cited by 7
“Four RCTs have evaluated the use of CGM compared with SMBG alone in pregnant women with T1D [31, 32, 34, 35].”
Characteristics of pregnancy complicated with type 1 and type 2 diabetes
Koyama, M., Taki, M., Okamoto, H., KAWAMURA, Y. L., Ueda, Y., Chigusa, Y., Mandai, M., & Mogami, H. (2023) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2023.07.005 · Cited by 7
A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
Kim, W. J., Kim, J. H., Yoo, H. J., Son, J. W., Khang, A. R., Kwon, S. K., Kim, J. H., Kim, T. H., Ryu, O. H., Park, K. H., et al. (2021) · Journal of Korean Diabetes · doi:10.4093/jkd.2021.22.4.225 · Cited by 7
Nosova, E. V., O’Malley, G., Dassau, E., & Levy, C. J. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13030 · Cited by 8
Alsahli, M. A., Alalwan, A., Aburisheh, K. H., Alarifi, F. F., Alshaya, H. M., Alkholaif, A. F., Shadid, A. M., Alsahli, S. A., Alsahly, A. A., & Alkhalifah, M. K. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1630_23 · Cited by 6
“[27] Poor glycemic outcomes even after the use of FSL have been associated with poor adherence to the management system and lowered use of the sensor.”
BackgroundGlycaemic control and novel technology management strategies in pregestational diabetes mellitus
Newman, C., Ero, A., & Dunne, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1109825 · Cited by 6
Tiselko, A. V., Yarmolinskaya, M. I., Владимировна, М. Е., & Milyutina, Y. P. (2020) · Diabetes Mellitus · doi:10.14341/dm10214 · Cited by 6
van Heerden, A. C., Kolozali, Ş., & Norris, S. A. (2022) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2022.2114408 · Cited by 6
Caring for pregnant women whose diabetes antedates pregnancy: is there room for improvement?
Sacks, D. A., & Feig, D. S. (2018) · Diabetologia · doi:10.1007/s00125-018-4565-7 · Cited by 6
“ing pregnancy did not result in glycaemic or neonatal improvements [25].”
BackgroundExploring Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review
Salmen, B.-M., Reurean‐Pintilei, D., Salmen, T., & Bohîlțea, R. E. (2025) · Life · doi:10.3390/life15091369 · Cited by 5
“…of the pregnancy has been associated with a lower risk of LGA, and improved neonatal outcomes: lower rates of macrosomia, leading to decreased rates of perinatal complications (i.e., shoulder dystocia), diminished rates of neonatal hypoglycaemia, and also lower rates of NICU admissions [43,44].”
Continuous glucose monitoring metrics in pregnancy with type 1 diabetes mellitus
Jeeyavudeen, M. S., Crosby, M., & Pappachan, J. M. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.90316 · Cited by 5
Diabetes Mellitus and Pregnancy
Szmuilowicz, E. D., Niznik, C. M., & Metzger, B. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64972-3 · Cited by 5
Outcomes of pregnancies complicated by type 2 diabetes
Scairati, R., McEvoy, R. P., Newman, C., & Dunne, F. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102054 · Cited by 4
Dutta, D., Jena, S., Mahajan, K., Kamrul-Hasan, A. B. M., Mohindra, R., & Singla, R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70743 · Cited by 4
Khan, A. A., Ata, F., Alsharkawy, N. A. A. S., Othman, E. M. M., Hassan, I. M., Taha, F. A. M., Baagar, K. A. M., Ali, H. A., Konje, J. C., Abou‐Samra, A., et al. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2354471 · Cited by 4
Impact of continuous glucose monitoring on pregnancy outcomes in women with pregestational diabetes
Hinojal, I., Chimenea, Á., Antiñolo, G., & García‐Díaz, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-024-02439-2 · Cited by 4
“Secher et al. studied 79 patients [19], while other clinical trials had even smaller sample sizes.”
InfluentialWhite, S. L., Brackenridge, A., & Rajasingam, D. (2016) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12268 · Cited by 4
Isabel, M., Cancela, J., Fico, G., Facchinetti, A., Cobelli, C., & Arredondo, M. T. (2014) · IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI ...) · doi:10.1109/bhi.2014.6864350 · Cited by 5
“The electronic databases consulted in this review were those related to technology, bioengineering, biomedicine and diabetes research: Diabetes Care Journals [6], [8]–[10], [21], [24], Diabetes Technology & Therapeutics [1], [3], [4], [12]–[15], [18], [20], [22], [25], [27], [29], IEEE Reviews in Biomedical Engineerin…”
BackgroundMethodDiabetes Mellitus and Pregnancy
Metzger, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00045-7 · Cited by 4
Wang, R., Zhang, Y., Zeng, H., Xiao, J., Qi, M., Bao, L., Jiao, R., Liu, J., Li, Y.-C., He, S., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/1021066 · Cited by 3
The effect of continuous glucose monitoring on neonatal outcomes in pregnant women with diabetes
Lai, X., Yu, J., 朱书涛, Zhang, K., & Ye, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1815133 · Cited by 3
Chen, X., Kim, G. E., Kim, N. A., & Kim, K. J. (2026) · Healthcare · doi:10.3390/healthcare14081019 · Cited by 3
Kodama, S., Fujihara, K., Yagyuda, N., Yachi, Y., Horikawa, C., Takeda, Y., Morikawa, S. Y., Yamada, T., Kato, K., Nakagawa, Y., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/3490884 · Cited by 3
Nofal, A. A., Benkhadra, K., Abbas, A. S., Nduwimana, M.-J., Al-Kordi, M., Allababidi, A. K., Wyckoff, J., Lapolla, A., Prokop, L. J., Wang, Z., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf289 · Cited by 3
Bradley, P. K., Duprey, M., & CASTORINO, K. N. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0710-6 · Cited by 3
“compliance due to inaccuracy and alarm fatigue [19].”
BackgroundMaternal diabetes and neonatal outcome
Varlas, V. N., Ciocârlan, M., Bohîlțea, R. E., & Dima, V. (2021) · Romanian Journal of Pediatrics · doi:10.37897/rjp.2021.4.8 · Cited by 3
7. Management of hyperglycemia during pregnancy
(2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30015-1 · Cited by 3
Relevancia del monitoreo continuo de glucosa en la práctica clínica: revisión de la evidencia
Gómez, A. M., Carrillo, D. C. H., Tapoada, L., & Toro, M. R. (2018) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.5.3.432 · Cited by 3
Famurewa, O. (2021) · Massey Research Online (Massey University) · Cited by 3
Jemai, C., Htira, Y., Salem, A., Ali, Z. H., Lajili, O., Hedfi, I., Amara, S. B., & Mami, F. B. (2026) · Nutrition and Metabolic Insights · doi:10.1177/11786388251408962 · Cited by 2
Ali, S. N., & Dornhorst, A. (2018) · Wiley eBooks · doi:10.1002/9781119211457.ch9 · Cited by 2
Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment
Amigó, J., & Corcoy, R. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.06.008 · Cited by 2
Wang, T., & Zhang, W. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.893148 · Cited by 2
Advances in pharmacological treatment of type 1 diabetes during pregnancy
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Παπάνας, Ν. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1593372 · Cited by 2
“clear benefit of RTCGM over SMBG was seen [72].”
BackgroundAmigó, J., & Corcoy, R. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.09.005 · Cited by 2
Millard, L. A. C., Patel, N., Tilling, K. M., Lewcock, M., Flach, P. A., & Lawlor, D. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/500256 · Cited by 2
on behalf of the CONCEPTT Collaborative Group, Feig, D. S., Asztalos, E. V., Corcoy, R., de Leiva, A., Donovan, L., Hod, M., Jovanovič, L., Keely, E., Kollman, C., et al. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1036-3 · Cited by 2
Garabédian, C., Sénat, M., Sananès, N., Berveiller, P., Brillac, T., Lous, M. L., Lemaître, M., Mitanchez, D., Morel, O., Paquin, S., et al. (2025) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2025.12.001 · Cited by 1
Glucose monitoring in the management of diabetes in pregnancy: A systematic review and meta‐analysis
Burk, J., & Sweeting, A. (2025) · Pregnancy · doi:10.1002/pmf2.70214 · Cited by 1
Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring
McCloskey, S. M., Biggio, J., Morgan, J. A., Mussarat, N., Toppin, J. D., Sternlieb, S. J., Manuel, N. E., Juracek, K., Shu, S., Stone, J., et al. (2026) · American Journal of Perinatology · doi:10.1055/a-2781-7373 · Cited by 1
Pal, A. W., Chong, W. L., Huri, H. Z., & Ratnasingam, J. (2026) · Diabetic Medicine · doi:10.1111/dme.70360 · Cited by 1
“While skin irritation was primarily an issue with older devices, 37 the ongoing financial burden of modern sensors continues to limit widespread adoption, particularly in under-resourced settings where out- of-pocket costs prohibit continuous access.”
InfluentialReal-Time Continuous Glucose Monitoring in Adult Outpatients
Bonomo, M. A., Grassi, G., Bartolo, P. D., & Maran, A. (2014) · Frontiers in diabetes · doi:10.1159/000363482 · Cited by 1
Vinagre, I., Giménez, M., Pericot, A., Bellart, J., & Conget, I. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.02.002 · Cited by 1
Update 2014 zu Diabetes und Schwangerschaft
Kleinwechter, H. J. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1191-3 · Cited by 1
Effective Postprandial Glucose Management in Pregnancy with Type 1 Diabetes
Polsky, S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0143 · Cited by 1
Excessive Gestational Weight Gain and Pregnancy Outcomes in Gestational and Pre-gestational Diabetes
Egan, A. M., & Dunne, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_31 · Cited by 1
Using Continuous Glucose Monitoring for Diabetes Mellitus in Pregnancy
Ma, X. J., & Zhou, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_16 · Cited by 1
Tiselko, A. V., Yarmolinskaya, M. I., Borovik, N. V., Suslova, S. V., Владимировна, М. Е., & Milutina, Y. P. (2020) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20202006156 · Cited by 1
Cundy, T. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch61 · Cited by 1
Kgosidialwa, O., Bogdanet, D., Egan, A. M., Newman, C., O’Shea, P. M., Biesty, L., McDonagh, C., O'Shea, C., Devane, D., & Dunne, F. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16842 · Cited by 1
Vestgaard, M. J., Al‐Saudi, E., Ásbjörnsdóttir, B., Nørgaard, L. N., Pedersen, B. W., Ekelund, C. K., Ringholm, L., Andersen, L. L. T., Jensen, D. M., Tabor, A., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14722 · Cited by 1
Self-citationIl monitoraggio in continuo della glicemia: stato dell’arte
Irace, C., & Molfetta, S. D. (2022) · il Diabete · doi:10.30682/ildia2204g · Cited by 1
Woon, L., Glyn, T., Gorelik, A., Yahya, R. H., & Price, S. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2428391 · Cited by 1
Nunlee‐Bland, G., Mitchell, R. D., Reeves, I. V., & Young, M. A. (2025) · Diabetes Spectrum · doi:10.2337/ds25-0034 · Cited by 1
Canciani, G. N., Stewart, Z. A., & Murphy, H. R. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch16 · Cited by 1
Novel insights into the management of diabetes in pregnancy
Voormolen, D. N. (2017) · Utrecht University Repository (Utrecht University) · Cited by 1
Codarin, R. R. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-17072018-121335 · Cited by 1
Glycaemic control in pregnancies complicated by type 1 diabetes
Stewart, Z. A. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.23269 · Cited by 1
Metadata
- Authors
- Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Steno Diabetes Center, Gentofte, Denmark
- Corresponding author
- Secher, Anna L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-06-12
- Volume
- 36
- Issue
- 7
- Pages
- 1877-1883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3687305
- OpenAlex
- W2107291591
- Cited by
- 214
- References
- 36
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 15 · 2023: 9 · 2022: 17 · 2021: 18 · 2020: 12 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 20 · 2015: 14 · 2014: 11 · 2013: 12
- FWCI
- 21.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- real-time continuous glucose monitoring, pregnancy, pregestational diabetes, type 1 diabetes, type 2 diabetes, glycemic control, HbA1c, severe hypoglycemia, large for gestational age, perinatal outcomes, gestational diabetes management
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy Outcome, Blood Glucose Self-Monitoring, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
